Skip to content
Home/Companies/Healthcare/Alderley Analytical
AA

Alderley Analytical

Healthcare·UK·Exited 2024·Held 9yr

Alderley Analytical is a healthcare company, headquartered in UK.

Entry
2015
Hold
9yr
Exit
2024
Est. EV
–

Who owns Alderley Analytical?

Alderley Analytical was owned by River Capital through NW Fund for Biomedical (2010 vintage) from 2015 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-30

River Capital
Investor
River Capital
NW Fund for Biomedical · 2010 · Healthcare

Key facts

HQUK
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from NW Fund for Biomedical

Other portfolio companies in the same fund.

Perfectus Biomed Group
Exited 2022
MedTechUK· 2013
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings